Through the 90-day period concluding February 07, 2026, Avalo Therapeutics's top three insider stakeholders include Chief Executive Officer Garry Arthur Neil (47.14K shares), Chief Financial Officer Christopher Ryan Sullivan (17.34K shares), Director June Sherie Almenoff (4.17K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital, Llc Armistice | 3,107 | 18 May, 2021 | |
| Garry Arthur Neil | Chief Executive Officer | 47,140 | 01 Apr, 2025 |
| James Archie Jr Harrell | Chief Commercial Officer | 0 | 14 Dec, 2021 |
| H Jeffrey Wilkins | Chief Medical Officer | 0 | 14 Dec, 2021 |
| Christopher Ryan Sullivan | Chief Financial Officer | 17,338 | 12 Dec, 2025 |
| June Sherie Almenoff | 4,167 | 01 Apr, 2025 | |
| Schond L. Greenway | Cfo | 0 | 14 Dec, 2021 |
| Paul Varki | Chief Legal Officer | 3,634 | 12 Dec, 2025 |
| Mittie Doyle | Chief Medical Officer | 3,622 | 12 Dec, 2025 |
| Gilla Kaplan | 3,167 | 01 Apr, 2025 | |
| Mitchell Chan | 3,167 | 01 Apr, 2025 | |
| Aaron Kantoff | 3,167 | 01 Apr, 2025 | |
| Samantha Truex | 3,167 | 01 Apr, 2025 | |
| Jennifer Riley | Chief Strategy Officer | 2,655 | 12 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Dec, 2025 | Paul Varki | Common Stock | D | 1,016 | $4.10 | 3,634 | D | F |
| 10 Dec, 2025 | Christopher Ryan Sullivan | Common Stock | D | 155 | $4.10 | 17,338 | D | F |
| 10 Dec, 2025 | Mittie Doyle | Common Stock | D | 1,013 | $4.10 | 3,622 | D | F |
| 10 Dec, 2025 | Jennifer Riley | Common Stock | D | 637 | $4.10 | 2,655 | D | F |
| 14 Nov, 2025 | Jonathan Goldman | Common Stock | D | 3,167 | $14.30 | 0 | D | S |
| 14 Nov, 2025 | Jonathan Goldman | Common Stock | A | 8,200 | $9.88 | 8,200 | D | M |
| 14 Nov, 2025 | Jonathan Goldman | Common Stock | D | 8,200 | $14.35 | 0 | D | S |
| 28 Mar, 2025 | Gilla Kaplan | Common Stock | A | 3,167 | - | 3,167 | D | M |
| 28 Mar, 2025 | June Sherie Almenoff | Common Stock | A | 3,167 | - | 3,167 | D | M |
| 28 Mar, 2025 | Garry Arthur Neil | Common Stock | A | 64,867 | - | 64,927 | D | M |
| 28 Mar, 2025 | Garry Arthur Neil | Common Stock | D | 17,787 | $8.46 | 47,140 | D | F |
| 28 Mar, 2025 | Garry Arthur Neil | - | - | 47,140 | D | |||
| 28 Mar, 2025 | Mitchell Chan | - | - | 3,167 | D | |||
| 28 Mar, 2025 | Mitchell Chan | Common Stock | A | 3,167 | - | 3,167 | D | M |
| 28 Mar, 2025 | Christopher Ryan Sullivan | Common Stock | D | 7,285 | $8.46 | 16,921 | D | F |
| 28 Mar, 2025 | Christopher Ryan Sullivan | Common Stock | A | 24,200 | - | 24,206 | D | M |
| 28 Mar, 2025 | Aaron Kantoff | Common Stock | A | 3,167 | - | 3,167 | D | M |
| 28 Mar, 2025 | Jonathan Goldman | Common Stock | A | 3,167 | - | 3,167 | D | M |
| 28 Mar, 2025 | Samantha Truex | Common Stock | A | 3,167 | - | 3,167 | D | M |
| 13 Nov, 2024 | June Sherie Almenoff | - | - | 1,000 | I |